Evidence map›Paper›PMID 38069999›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2024

Combined Angiotensin Inhibition for CKD: The Truth Is Rarely Pure and Never Simple.

Anand Srivastava, Insa M Schmidt, Ragnar Palsson

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Anand SrivastavaDivision of Nephrology, Department of Medicine, University of Illinois Chicago, Chicago, Illinois.
Insa M SchmidtSection of Nephrology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts; Hamburg Center for Kidney Health, University Medical Center Hamburg, Hamburg, Germany.
Ragnar PalssonDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: rpalsson1@bwh.harvard.edu.

Funding

ConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2021
$21.0M
Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant ImmunosuppressionU01AI163081 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Justin Boike, Paolo Cravedi · 2021 to 2026
$11.3M
Non-Invasive Imaging Biomarkers to Identify a High-Risk Chronic Kidney Disease PhenotypeK23DK120811 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SRIVASTAVA, ANAND · 2020 to 2024
$1.0M
NIAID NIH HHS U01 AI163081NIDDK NIH HHS K23 DK120811NIDDK NIH HHS U2C DK114886
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney Failure, ChronicRenal Insufficiency, ChronicAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAngiotensinsHumansRenin-Angiotensin SystemAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAngiotensins

Identifiers

PMID38069999
PMCPMC12085227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.